FDA Approves ACTOplus met(R) XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes First and only oral antidiabetic fixed-dose combination medication ...
LINCOLNSHIRE, Ill. – Takeda Global Research & Development Center (TGR&D) today announced that the company has submitted a New Drug Application (NDA) for an extended-release version of the combination ...
DEERFIELD, Ill., October 14, 2009 – A study, published online in the journal Current Medical Research and Opinion, showed that a greater percentage of patients with type 2 diabetes treated with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback